Clinical relevance of deferasirox trough levels in β‐thalassemia patients

E-ISSN： 1440-1681|45|2|213-216

ISSN： 0305-1870

Source： CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol.45, Iss.2, 2018-02, pp. : 213-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Treatment Satisfaction and Convenience with Deferasirox in Iron-Overloaded Patients with β-Thalassemia: Results from the ESCALATOR Trial

Acta Haematologica, Vol. 123, Iss. 4, 2010-04 ,pp. : 220-225

Karger

Access to resources Recommend Favorite

The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β‐thalassemia major: A prospective, single center, open‐label study

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1592-1596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lung Function in β-Thalassemia Patients: A Longitudinal Study

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 25-29

Karger

Access to resources Recommend Favorite

Higher Serum Ferritin Levels Correlate with an Increased Risk of Cutaneous Morbidity in Adult Patients with β-Thalassemia: A Single-Center Retrospective Study

Acta Haematologica, Vol. 135, Iss. 2, 2016-0 ,pp. : 124-130

Karger

Access to resources Recommend Favorite

The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia

Acta Haematologica, Vol. 135, Iss. 4, 2016-01 ,pp. : 193-199

Karger

Access to resources Recommend Favorite